Download Stanford Profiles: /viewCV

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
Curriculum Vitae
KAY W CHANG, MD
Office address:
801 Welch Road
Stanford, CA 94305
Office: (650) 736-1314
PRESENT POSITION
Associate Professor, Department of Otolaryngology, Stanford University
March 1, 2008 – present
Assistant Professor, Department of Otolaryngology, Stanford University
August 16, 2000 – February 29, 2008
EDUCATION
Brown University, Providence, RI
B.A. (Cognitive and Linguistic Sciences) magna cum laude, 1985-89
Brown University School of Medicine, Providence, RI
M.D. Sigma Xi, 1988-92
POSTGRADUATE TRAINING
Surgery Intern, University of Washington, Seattle, WA, 1992-93
Otolaryngology Postdoctoral Research Fellow, University of Washington, Seattle, WA, 1993-94
Otolaryngology Resident, University of Washington, Seattle, WA, 1994-98
Pediatric Otolaryngology Fellow, Children’s Hospital of Pittsburgh, PA, 1998-2000
LICENSURE AND CERTIFICATION
American Board of Otolaryngology (Certificate # 15149), 1999
State of California (License # G85741), 2000
PROFESSIONAL SOCIETIES
American Academy of Otolaryngology–Head and Neck Surgery (AAO-HNS), 1994
Pediatric Otolaryngology Committee, appointed 10/1/09 – 9/30/2011
CPT/RVU Committee, ASPO SSAC representative, 3/2011 – 9/30/2015
Hearing Committee, appointed 10/1/13 – 9/30/2017
AAO-HNS Foundation Honor Award, 2013
Association for Research in Otolaryngology (ARO), 1995
Children’s Oncology Group (COG), 2003
Society for Ear, Nose and Throat Advances in Children (SENTAC), 2004
American Society of Pediatric Otolaryngology (ASPO), 2005
Pediatric Otology Study Group, 2007Nominating Committee, 2009-2010, 2014
Membership Committee, 2010-2012
Finance Committee, 2010-12
Chair of Finance Committee, 2012-14
Audit Committee, 2014-16
Curriculum Vitae
Kay W. Chang, MD
International Society of Pediatric Oncology (SIOP)
Co-Chair Ototoxicity Consensus Conference, October 2010
Triologic Society, 2011
Program Advisory Committee for Combined Sections Meeting, Hotel del Coronado, San
Diego, CA, January 22-24, 2015
American Otological Society (AOS), 2014
International Society for Auricular Reconstruction (ISAR), 2014
Presented keynote at 1st Congress of the International Society of Auricular
Reconstruction, Paris, France, September 27, 2014
HONORS AND AWARDS
USA Presidential Scholar (Connecticut), 1985
Phi Beta Kappa, 1988
Magna Cum Laude, Brown University, 1989
Milton Hamolsky Prize, to outstanding PLME graduate, 1989
Leonard H. Campbell Scholarship, Brown University School of Medicine, 1991
Henry Randall Prize, to outstanding MD graduate planning a surgical career, 1992
Sigma Xi, 1992
Sigma Xi Award, for outstanding medical research, 1992
1995 Association for Research in Otolaryngology Resident Travel Award
Resident Teacher of the Year Award, Department of Otolaryngology, Stanford University, 2003
“Excellence in Teaching” award for medical student teaching, Stanford University, 2004
Best Doctors in America, 2005-2016
America’s Registry of Outstanding Professionals, 2006
Resident Teacher of the Year Award, Department of Otolaryngology, Stanford University, 2010
Patients’ Choice Award, 2011-2014
Top Ten Doctors (Vitals), 2012-2013
Castle Connolly’s Top Doctors, 2012-2015
AAO-HNS Foundation Honor Award, 2013
GRANTS
Efferent regulation of the cochlear amplifier. Deafness Research Foundation (1996) $15,000.
SERVICE TO STANFORD UNIVERSITY / LUCILE PACKARD CHILDREN’S HOSPITAL
LPCH Care Improvement Committee, 2001-2011
Director of Medical Student Programs, Dept. of Otolaryngology, 2002-2011
LPCH Policy Committee, 2004-2005
2
Curriculum Vitae
Kay W. Chang, MD
MD Cerner Advisory Committee, 2005
Stanford Medical School Faculty Senate, 2005-2008
Ped/OB FPO Finance Committee, 2005-present
Committee for Courses and Curriculum (CCC) Physical Exam Task Force, 2006-2010
Stanford Faculty Fellows Program, 2009
Advanced Stanford Leadership Development Program, 2012
LPCH Perioperative Services RPI #9: ENT Patient Flow, Physician lead, 2012
LPCH Enterprise-Wide Scheduling Initiative, Physician Leadership, Executive Steering
Committee, 2012
LPCH Information Services Physician Advisory Group (ISPAG), 2012-present
SERVICE TO PROFESSIONAL PUBLICATIONS
Otology and Neurotology (Editorial Board, 2012-)
Manuscript Reviewer, 2001Otolaryngology-Head and Neck Surgery (Editorial Board, 2009-2014)
Manuscript Reviewer, 2004Received “Top Ten Reviewer” award for 2009
Cleft Palate Craniofacial Journal
Manuscript Reviewer, 2003Pediatric Blood & Cancer
Manuscript Reviewer, 2003Journal of Clinical Oncology
Manuscript Reviewer, 2004American Journal of Rhinology
Manuscript Reviewer, 2005Experimental Biology and Medicine
Manuscript Reviewer, 2006Journal of Pediatrics
Manuscript Reviewer, 2008Archives of Otolaryngology—Head & Neck Surgery
Manuscript Reviewer, 2008International Journal of Pediatric Otorhinolaryngology
Manuscript Reviewer, 2009Postgraduate Medical Journal
Manuscript Reviewer, 2009Archives of Disease in Childhood
Manuscript Reviewer, 2009Pediatrics
Manuscript Reviewer, 2010-
3
Curriculum Vitae
Kay W. Chang, MD
4
Journal of Pediatric Hematology and Oncology
Manuscript Reviewer, 2010Journal of Medical Screening
Manuscript Reviewer, 2010Pediatric Pulmonology
Manuscript Reviewer, 2010Laryngoscope
Manuscript Reviewer, 2011Annals of Otology, Rhinology, and Laryngology
Manuscript Reviewer, 2011Chemotherapy
Manuscript Reviewer, 2012Medicinal Research Reviews
Manuscript Reviewer, 2014PEER REVIEWED PUBLICATIONS
PUBLISHED
1. Chang KW, Vohr BR, Norton SJ, Lekas MD. External and middle ear status related to evoked
otoacoustic emission in neonates. Arch Otolaryngol Head Neck Surg, 1993;119:276-282. [impact
factor 2.33]
2. McRae RG, Weissburg AJ, Chang KW. Iatrogenic hyponatremia: a cause of death following
pediatric tonsillectomy. Int J Pediatr Otorhinolaryngol, 1994;30:227-232. [impact factor 1.4]
3. Chang KW, Norton SJ. The effects of continuous versus interrupted noise exposures on
distortion product otoacoustic emissions in guinea pigs. Hearing Research, 1996;96:1-12.
[impact factor 3.14]
4. Chang KW, Inglis AF. Evaluation and management of hoarseness in children. Current Opinion
Oto Head Neck Surg, 1996;4:396-400. [impact factor 2.0]
5. Chang KW, Norton SJ. Efferently mediated changes in the quadratic distortion product (f2 f1). J Acoust Soc Am , 1997;102:1719-1733. [impact factor 1.74]
6. Steinbach WJ, Sectich TC, Benjamin DK, Chang KW, Messner AH (2002) Pediatric residents’
clinical diagnostic accuracy of otitis media. Pediatrics, 2002;109(6):993-8. [impact factor 6.2]
7. Choe W, Chinosornvatana N, Chang KW. Prevention of Cisplatin ototoxicity using
transtympanic N-acetylcysteine and lactate. Otology & Neurotology, 2004;25(6):910-5. [impact
factor 2.0]
8. Katzenstein HM, Chang K, Krailo M, Bowman L, Greffe B, Castleberry R, Malogolowkin M. A
randomized study of platinum-based chemotherapy with or without amifostine for the
treatment of children with hepatoblastoma: A report of the Intergroup Hepatoblastoma Study
P9645. Proc Am Soc Clin Oncol. 2004;22:8518.
9. Chang KW. Randomized controlled trial of Coblation versus electrocautery tonsillectomy.
Otolaryngol Head Neck Surg, 2005;132(2):273-80. [impact factor 2.0]
10. Agarwal S, Hong DK, Soslow J, Chang KW. Not your routine foreign body: Endobronchial
tuberculosis in an infant. Pediatrics, 2005;116(1):246-8. [impact factor 6.2]
Curriculum Vitae
Kay W. Chang, MD
5
11. Marina N, Chang KW, Malogolowkin M, London WB, Frazier AL, Womer RB, Rescorla F,
Billmire DF, Davis MM, Perlman EJ, Giller R, Lauer SJ, Olson TA. Amifostine does not protect
against the ototoxicity of high-dose cisplatin, etoposide and pleomycin (HD-PEB) in pediatric
germ cell tumors (PGCT): A Children’s Oncology Group (COG) study. Cancer,
2005;104(4):841-7. [impact factor 5.4]
12. Rosen FS, Bingham D, Chang KW. Posttransplantation lymphoproliferative disorder of the
paranasal sinuses in a child. Int J Pediatr Otorhinolaryngol Extra, 2006;1(1):22-26. [impact factor
1.4]
13. Chen JL, Messner AM, Chang KW. Familial laryngomalacia in two siblings with syndromic
features. Int J Pediatr Otorhinolaryngol, 2006;70(9):1651-5. [impact factor 1.4]
14. Schrijver I, Chang KW. Two patients with the V37I/235delC genotype: Are radiographic
cochlear anomalies part of the phenotype? Int J Pediatr Otorhinolaryngol, 2006;70(12):2109-13.
[impact factor 1.4]
15. Truong MT, Winzelberg J, Chang KW. Recovery from cisplatin-induced ototoxicity. Int J
Pediatr Otorhinolaryngol, 2007;71(10):1631-1638. [impact factor 1.4]
16. Chang KW, Lee BG, Gutierrez KM. Third branchial cleft fistula infected with Actinomyces.
Int J Pediatr Otorhinolaryngol Extra, 2008;3(1):20-23. [impact factor 1.4]
17. Chen JL, Gittleman A, Barnes PD, Chang KW. Utility of temporal bone computed
tomographic measurements in the evaluation of inner ear malformations. Arch Otolaryngol
Head Neck Surg, 2008;134(1):50-56. [impact factor 2.33]
18. Chang KW. Intracapsular versus subcapsular Coblation tonsillectomy. Otolaryngol Head Neck
Surg, 2008;138(2):153-7. [impact factor 2.0]
19. Mogensen MA, Lin AC, Chang KW, Berry GJ, Barnes PD, Fischbein NJ. Salivary Gland
Anlage Tumor in a Neonate Presenting with Respiratory Distress: Radiographic and
Pathologic Correlation. Am J Neuroradiol. 2009;30(5):1022-3. [impact factor 3.9]
20. Chang KW, O-Lee TJ, Price M. Evaluation of unilateral referrals on neonatal hearing
screening. J Med Screening, 2009;16(1):17-21. [impact factor 3.1]
21. Curtin G, Messner AH, Chang KW. Otorrhea in infants with tympanostomy tubes before and
after surgical repair of a cleft palate. Arch Otolaryngol Head Neck Surg, 2009;135(8):748-51.
[impact factor 2.33]
22. Katzenstein HM, Chang KW, Krailo M, Chen Z, Bowman LC, Finegold MJ, Rowland J, Greffe
B, Reynolds M, Newman K, Womer R, Castleberry RP, Pappo A, London W, Malogolowkin M.
Amifostine does not prevent platinum-induced ototoxicity in children with hepatoblastoma.
A report of the Intergroup Hepatoblastoma Study P9645. Cancer, 2009;115(24):5828-35.
[impact factor 5.4]
23. Truong MT, Chang KW, Berk DR, Heerema-McKenney A, Bruckner AL. Propranolol for the
treatment of a life-threatening subglottic and mediastinal infantile hemangioma. J Pediatrics,
2010;156(2):335-8. [impact factor 4.2]
24. Chan DK, Schrijver I, Chang KW. Connexin-26-associated deafness: Phenotypic variability
and progression of hearing loss. Genet Med. 2010;12(3):174-81. [impact factor 7.33]
25. Chang KW, Chinosornvatana N. Practical grading system for evaluating cisplatin ototoxicity
in children. J Clin Onc. 2010;28(10):1788-95. [impact factor 18.4]
26. Truong MT, Perkins JA, Messner AH, Chang KW. Propranolol for the treatment of airway
hemangiomas: a case series and treatment algorithm. Int J Pediatr Otorhinolaryngol.
2010;74(9):1043-8. [impact factor 1.4]
Curriculum Vitae
Kay W. Chang, MD
6
27. Chan DK, Schrijver I, Chang KW. Diagnostic yield in the workup of congenital sensorineural
hearing loss is dependent on patient ethnicity. Otology & Neurotology, 2011;32(1):81-7. [impact
factor 2.0]
28. Kohlberg GD, Truong MT, Chang KW. Wegener’s granulomatosis in an adolescent presenting
with pachymeningitis, mastoid effusion and Horner’s syndrome. Int J Pediatr Otorhinolaryngol
Extra, 2011;6(2):80-84. [impact factor 1.4]
29. Chang KW. Clinically accurate assessment and grading of ototoxicity. (Triologic Thesis)
Laryngoscope, 2011;121(12):2649-57. [impact factor 2.33]
30. Mori M, Chang KW. CT analysis demonstrates that cochlear height does not change with age.
Am J Neuroradiol, 2012;33(1):119-23. [impact factor 3.9]
31. Gurgel RK, Popelka GR, Oghalai JS, Blevins NH, Chang KW, Jackler RK. Is it valid to
calculate the 3-kilohertz threshold by averaging 2 and 4 kilohertz? Otolaryngol Head Neck Surg,
2012;147(1):102-4. [impact factor 2.0]
32. Brock PR, Knight KR, Campbell KC, Steyger PS, Blakley BW, Rassekh SR, Chang KW, Fligor
BJ, Raijput K, Sullivan M, Neuwelt EA. Platinum-induced ototoxicity in children: a consensus
review on mechanisms, predisposition, and protection, including a new International Society
of Pediatric Oncology Boston ototoxicity scale. J Clin Onc, 2012;30(19):2408-17. [impact factor
18.4]
33. Chisholm KM, Chang KW, Truong MT, Kwok S, West RB, Heerema-McKenney AE. BAdrenergic receptor expression in vascular tumors. Modern Pathology, 2012 Nov;25(11):144651. [impact factor 6.2]
34. Huoh KC, Chang KW. Lip Abscess Associated with Isotretinoin Treatment of Acne Vulgaris.
JAMA Dermatology, 2013 Aug 1;149(8):960-1. [impact factor 4.8]
35. Nadaraja GS, Gurgel RK, Kim J, Chang KW. Hearing outcomes of atresia surgery versus
osseointegrated bone conduction device in patients with congenital aural atresia: a systematic
review. Otology & Neurotology, 2013 Oct;34(8):1394-9. [impact factor 2.0]
36. Chan DK, Chang KW. GJB2-associated hearing loss: Systematic review of worldwide
prevalence, genotype, and auditory phenotype. Laryngoscope, 2014 Feb;124(2):E34-53. [impact
factor 2.33]
37. Hoff SR, Chang KW. The proximal bronchoplasty retrieval technique for removal of
embedded distal airway foreign bodies. Int J Pediatr Otorhinolaryngol, 2014 Jan;78(1):148-51.
[impact factor 1.4]
38. Bass JK, Huang J, Onar-Thomas A, Chang KW, Bhagat SP, Chintagumpala M, Bartels U,
Gururangan S, Hassall T, Heath J, McCowage G, Cohn R, Fisher M, Robinson G, Broniscer A,
Gajjar A, Gurney JG. Concordance between the Chang and the International Society of
Pediatric Oncology (SIOP) ototoxicity grading scales in patients treated with cisplatin for
medulloblastoma. Pediatric Blood & Cancer, 2014 Apr;61(4):601-5. [impact factor 2.4]
39. Czechowicz JA, Chang KW. Analysis of growth curves in children after adenotonsillectomy.
JAMA Otolaryngol, 2014 Jun;140(6):491-6. [impact factor 1.8]
40. Colevas AD, Lira RR, Colevas EA, Lavori PW, Chang KW. Hearing evaluation of head and
neck cancer patients (HNCP): Comparison of CTCAE, Brock and Chang adverse event (AE)
criteria in patients receiving cisplatin. Head Neck, 2015;37(8):1102-7. [impact factor 2.73]
41. Czechowicz JA, Chang KW. Catch-up growth in infants with laryngomalacia after
supraglottoplasty. Int J Pediatr Otorhinolaryngol, 2015 Aug;79(8):1333-6. [impact factor 1.4]
Curriculum Vitae
Kay W. Chang, MD
7
42. Chang KW. Genetics of hearing loss – Nonsyndromic. Otolaryngol Clin North Am, 2015
Dec;48(6):1063-72. [impact factor 1.76]
43. Amoils M, Chang KW, Saynina O, Wise PH, Honkanen A. Perioperative complications in
pediatric tonsillectomy and adenoidectomy in ambulatory vs inpatient settings: Lessons
learned from administrative data query. JAMA Otolaryngology, 2016 Feb 25 [Epub ahead of
print] [impact factor 2.1]
44. Bass JK, Hua C, Huang J, Onar-Thomas J, Ness KK, Jones S, White S, Bhagat SP, Chang KW,
Merchant TE. Hearing loss in patients who received cranial radiation therapy for childhood
cancer. J Clin Onc, 2016 Jan 25. [Epub ahead of print] [impact factor 18.4]
45. Bass JK, Knight KR, Yock TI, Chang KW, Cipkala D, Grewal, SS. Evaluation and management
of hearing loss in survivors of childhood and adolescent cancers. Pediatric Blood & Cancer. 2016
Feb 29 [Epub ahead of print] [impact factor 2.4]
46. Shan J, Guo Y, Chang KW, Zhang T. A modified technique for firm elevation of the
reconstructed auricle. Eur Arch Otorhinolaryngol, 2016 Jan 18. [Epub ahead of print] [impact
factor 1.6]
BOOK CHAPTERS
1. Chang KW, Inglis AF. Sinusitis. Conn’s Current Therapy, 1997;Section 3:235-237.
2. Chang KW, Bluestone CD. Middle ear trauma. Gellis and Kagan's Current Pediatric Therapy
17th edition, 2002. p. 941.
3. Conner GH, Chang KW. Idiopathic conditions of the mouth and pharynx. Chapter 64
(pp.1242-1250). Pediatric Otolaryngology (ed: Bluestone, Stool, et al), 4th edition, 2003.
4. Messner AH, Chang KW. Pediatric Otolaryngology. Chapter 12.3 (pp.953-970).
Anesthesiologist’s Manual of Surgical Procedures (ed: Jaffe & Samuels), 3 rd edition, 2004.
5. Chang KW. Complications of otitis media. Audio-Digest Otolaryngology Volume 40 Issue 1,
January 7, 2007.
6. Chang KW. Atypical mycobacterial infections. Audio-Digest Otolaryngology Volume 40
Issue 1, January 7, 2007.
7. Chang KW. Laryngeal stenosis. Audio-Digest Otolaryngology Volume 41 Issue 18, September
21, 2008.
8. Chang KW. The latest techniques in tonsillectomy. Audio-Digest Otolaryngology Volume 41
Issue 24, December 21, 2008.
9. Messner AH, Chang KW, Chen M, Lammers CR, Hammer GB. Pediatric Otolaryngology.
Chapter 12.3 (pp.1179-1199). Anesthesiologist’s Manual of Surgical Procedures (ed: Jaffe RA
& Samuels SI), 4th edition, 2009.
10. Chang KW. How to avoid missing a cholesteatoma. Audio-Digest Otolaryngology Volume
44 Issue 13, July 7, 2011.
11. Hoff SR, Chang KW. Pharyngitis. Chapter 52 (pp.757-769). Bailey’s Head & Neck Surgery –
Otolaryngology (ed: Johnson & Rosen), 5th edition, 2014.
12. Chang KW. Ototoxicity. Chapter 158 (pp.2542-2555). Bailey’s Head & Neck Surgery –
Otolaryngology (ed: Johnson & Rosen), 5th edition, 2014.
13. Chang KW. Coblation techniques. Audio-Digest Otolaryngology Volume 47 Issue 23,
December 7, 2014.
Curriculum Vitae
Kay W. Chang, MD
8
14. Chang KW. Management of atresia and microtia. Audio-Digest Otolaryngology Volume 48
Issue 2, January 21, 2015.
ABSTRACTS
1. Chang KW, Norton SJ. Efferently mediated changes in the acoustic QDT. Eighteenth Midwinter
Meeting of the Association for Research in Otolaryngology, Feb. 5-9, 1995, St. Petersburg Beach,
Florida, p. 173.
2. Chang KW, Norton SJ. The efferents play a role in the adaptation of the cochlear amplifier to
acoustic stimulation. Nineteenth Midwinter Meeting of the Association for Research in
Otolaryngology, Feb. 4-8, 1996, St. Petersburg Beach, Florida, p. 23.
NATIONAL AND INTERNATIONAL PRESENTATIONS
1. Chang KW, Vohr BR, Norton SJ, Lekas MD. “External canal and middle ear status in full term
neonates related to evoked otoacoustic emission.” Presented at American Pediatric
Society/Society for Pediatric Research joint annual meeting, Baltimore, May 4-7, 1992.
2. McRae R, Weissberg A, Chang KW. “Iatrogenic hyponatremia: A cause of death following
pediatric tonsillectomy.” Presented at 1992 Eastern Section Meeting of the Triological Society,
The Grand Hyatt Hotel, New York, January 30, 1993.
3. Chang KW, Pinczower EF. “Stapes gusher.” Presented at Northwest Academy of
Otolaryngology Head and Neck Surgery Spring Meeting, Chateau Whistler Resort, Whistler,
British Columbia, April 12, 1997.
4. Chang KW, Darden D, Dohar J. “Pediatric tracheotomy - Is postoperative chest x-ray
necessary?” Presented at 14th Annual American Society of Pediatric Otolaryngology Meeting,
Marriott’s Desert Springs, Palm Desert, CA, April 28-30, 1999.
5. Chang KW, Casselbrant ML, Furman JM, Redfern MS, Mandel EM, Fall PA. “Otitis media and
balance.” Presented at 7th International Symposium on Recent Advances in Otitis Media,
Marriott Harbor Beach Resort, Fort Lauderdale, FL, June 1-5, 1999.
6. Chang KW. “Lye Ingestion.” Presented at American Society of Pediatric Otolaryngology,
Eastern Section Meeting, Hilton Hotel, Pittsburgh, PA, January 28, 2000.
7. Chang KW. “Cisplatin ototoxicity.” Invited guest for Children’s Oncology Group 2003 Spring
Group Meeting, Atlanta, Georgia. Rare Tumor Committee, Germ Cell Tumor Subcommittee,
March 27, 2003.
8. Marina N, Malogolowkin M, Chang KW, London WB, Frazier AL, Rescorla F, Billmire DF, Davis
M, Perlman E, Giller R, Lauer S. “Amifostine does not protect against the ototoxicity associated
with high-dose cisplatin, etoposide, and bleomycin (HD-PEB) in pediatric germ cell tumors.”
Children’s Oncology Group 2003 Fall Group Meeting, Dallas, Texas, November 4-9, 2003.
9. Choe W, Chinosornvatana N, Chang KW. “Anti-oxidant prevention of cisplatin ototoxicity.”
American Otologic Society Spring COSM, Phoenix, Arizona, May 1-2, 2004.
10. Chang KW. “Randomized controlled trial of Coblation versus electrocautery tonsillectomy.”
AAO-HNS Annual Meeting, New York City, Sept 20, 2004.
11. Schrijver I, Chang KW. “Two patients with the V37I/235delC genotype: Are radiographic
cochlear anomalies part of the phenotype?” 5th Molecular Biology of Hearing and Deafness
Conference, Bethesda, Maryland, Sept 30-Oct 3, 2004.
Curriculum Vitae
Kay W. Chang, MD
9
12. Messner AH, Chang KW, Friedman N. “Obstructive Sleep Apnea – What Do We Look For?”
American Academy of Pediatrics 2004 National Conference & Exhibition, Moscone Convention
Center, San Francisco, CA, October 9, 2004.
13. Monfared A, Blevins NH, Cheung ELM, Jung J, Popelka G, Chang K, Jackson R, Schnitzer M.
“Fluorescence microendoscopy of the mammalian inner ear.” American Neurotology Society
Spring COSM, Boca Raton, Florida, May 14-15, 2005.
14. Koltai P, Chang K, Gianonni C, April M. “Controversies in tonsillectomy surgery.” American
Society of Pediatric Otolaryngology 2005 Annual Meeting, Las Vegas, Nevada, May 27-30, 2005.
15. Chang KW. “Tonsil surgery in the 21st Century: different opinions.” Moderator. 6th
International Symposium on Tonsils and Mucosal Barriers of the Upper Airways (I.S.T.M.B.),
Siena, Italy, August 31 – September 3, 2006.
16. Chang KW. “Coblation tonsillectomy.” 6th International Symposium on Tonsils and Mucosal
Barriers of the Upper Airways (I.S.T.M.B.), Siena, Italy, September 1, 2006
17. Chang KW. “Expanding indications for BAHA.” SENTAC Pre-conference Symposium,
Improving Auditory (re)Habilitation, San Francisco, November 30, 2006
18. Chang KW, Kazahaya K, O’Reilly R, Arjmand E, Papaioannou V, Larky J, Gordon K. “Bilateral
Cochlear Implantation” SENTAC Panel, San Francisco, December 1, 2006.
19. Chang KW. “Intracapsular versus subcapsular Coblation tonsillectomy.” SENTAC 34th Annual
Meeting, San Francisco, December 2, 2006.
20. Curtin G, Messner A, Chang KW, Silva WJ, Diamond M. “Optimizing care for patients in a
pediatric long-term care facility.” SENTAC 34th Annual Meeting, San Francisco, December 3,
2006
21. Chang K. “Coblation tonsillectomy techniques.” Northwest and Oregon Academies of
Otolaryngology Mid-Winter Meeting, Whistler BC, January 15, 2007.
22. Papsin B, Sie K, Brenski A, Chang K, Manning S. “Pediatric conductive hearing loss, BAHA,
and atresia.” Northwest and Oregon Academies of Otolaryngology Mid-Winter Meeting,
Whistler BC, January 15, 2007.
23. Chen J, Chang KW. “Utility of temporal bone CT measurements in the evaluation of inner ear
malformations.” American Society of Pediatric Otolaryngology 2007 Annual Meeting, San
Diego, California, April 29, 2007.
24. O-Lee TJ, Price M, Chang KW. “Evaluation of unilateral refers on neonatal hearing screening.”
American Society of Pediatric Otolaryngology 2007 Annual Meeting, San Diego, California,
April 27-29, 2007.
25. Truong MT, Koltai PJ, O-Lee TJ, Messner AH, Chang KW. “Pediatric Sleep Endoscopy.”
American Academy of Otolaryngology-Head and Neck Surgery 2007 Annual Meeting,
Washington DC, September 17, 2007.
26. Koltai P, Chang K. “Intracapsular tonsillectomy: Microdebrider and Coblation.” American
Academy of Otolaryngology-Head and Neck Surgery 2007 Annual Meeting, Course # 3834-1,
Washington DC, September 18, 2007.
27. Chang KW. “The latest techniques in tonsillectomy.” UCSF Otolaryngology Update: 2007, San
Francisco, CA, November 8, 2007.
28. Swamy R, Chang K, Winzelberg J. “Longitudinal audiologic evaluation of children with Downs
syndrome.” American Society of Pediatric Otolaryngology 2008 Annual Meeting, Orlando,
Florida, May 2-4, 2008.
Curriculum Vitae
Kay W. Chang, MD
10
29. Papsin B, Chang K, Mileshina N, Unal O. “Microtia, Aural Atresia Round Table.” 8 th
International Conference of the European Society of Pediatric Otolaryngology, Budapest,
Hungary, June 10, 2008.
30. Chang KW, Huang E, Carlson GA, Vose JG. “Evaluation of the PEAK PlasmaBlade for ENT
surgery.” American Academy of Otolaryngology-Head and Neck Surgery 2008 Annual
Meeting, Chicago, IL, September 21, 2008.
31. Koltai P, Chang K. “Intracapsular tonsillectomy: Microdebrider and Coblation.” American
Academy of Otolaryngology-Head and Neck Surgery 2008 Annual Meeting, Course # 2729-1,
Chicago, IL, September 22, 2008.
32. Chan DK, Schrijver I, Chang KW. “Evidence for progression in Connexin-26-associated hearing
loss.” American Society of Pediatric Otolaryngology 2009 Annual Meeting, Seattle, Washington,
May 23, 2009.
33. Truong MT, Callahan K, Bruckner A, McKenney A, Chang K. “Oral propranolol; The end to
surgical management of subglottic hemangiomas?” American Society of Pediatric
Otolaryngology 2009 Annual Meeting, Seattle, Washington, May 24, 2009.
34. Mori M, Chang K. “CT analysis shows cochlear height does not change with age.” American
Academy of Otolaryngology-Head and Neck Surgery 2009 Annual Meeting, San Diego, CA,
October 4-7, 2009.
35. Koltai P, Chang K. “Intracapsular tonsillectomy: Microdebrider and Coblation.” American
Academy of Otolaryngology-Head and Neck Surgery 2009 Annual Meeting, Course # 3832-1,
San Diego, CA, October 6, 2009.
36. Truong MT, Chang K, Messner A. “Propranolol for the treatment of airway hemangiomas.”
American Academy of Otolaryngology-Head and Neck Surgery 2009 Annual Meeting, San
Diego, CA, October 7, 2009.
37. Kohlberg GD, Truong MT, Chang KW. “Wegener’s granulomatosis in an adolescent presenting
with pachymeningitis, mastoid effusion and Horner’s syndrome.” SENTAC 37 th Annual
Meeting, Salt Lake City, UT, December 3-6, 2009.
38. Chan DK, Schrijver I, Chang KW. “Connexin 26-associated deafness: Association of a single
common allele with progressive hearing loss.” American Otologic Society Spring COSM, Las
Vegas, NV, May 1, 2010.
39. Chang KW, Knight K. “Clinical study of ototoxicity in children.” 42 nd Congress of the
International Society of Pediatric Oncology (SIOP), Ototoxicity Consensus Conference, Boston,
MA, October 23-24, 2010.
40. Chisholm KM, Chang KW, Truong MT, Kwok S, West RB, Heerema-McKenney A. “Beta
adrenergic receptor expression in pediatric vascular lesions.” Society for Pediatric Pathology
2011 Annual Meeting, San Antonio, TX, February 27, 2011.
41. Brewer C, Knight K, Fligor B, Grimes A, Brooks B, Chang K. “Guidelines for monitoring and
grading pediatric ototoxicity.” American Academy of Audiology AudiologyNOW! 2011 Annual
Meeting, Chicago, IL, April 8, 2011.
42. Gurgel RK, Popelka G, Oghalai JS, Blevins NH, Chang KW, Jackler R. “Correlation of measured
versus averaged 3 kHz pure tone averages.” American Academy of Otolaryngology-Head and
Neck Surgery 2011 Annual Meeting, San Francisco, CA, September 14, 2011.
43. Colevas AD, Lira RR, Colevas EA, Lavori PW, Chang KW. “Hearing evaluation of head and
neck cancer patients (HNCP): Comparison of adverse event (AE) criteria.” American Society of
Curriculum Vitae
Kay W. Chang, MD
11
Clinical Oncology (ASCO) 2012 Annual Meeting, Chicago, IL, June 1-5, 2012. citation: J Clin
Oncol 30, 2012 (suppl; abstr 5525)
44. Hoff SR, Chang KW. “Stuck: Proximal balloon dilation technique for removal of embedded
distal airway foreign bodies.” American Academy of Otolaryngology-Head and Neck Surgery
2012 Annual Meeting, Washington, DC, September 10, 2012.
45. Chan DK, Chang KW. “GJB2 associated hearing loss: Systematic review of worldwide
prevalence, genotype, and auditory phenotype.” Triological Society 116 th Annual Meeting
Spring COSM, Orlando, FL, April 12, 2013.
46. Nadaraja GS, Gurgel RK, Chang KW. “Hearing outcomes of atresia surgery versus boneanchored hearing aid in patients with congenital aural atresia: A systematic review.” American
Otological Society 146th Annual Meeting Spring COSM, Orlando, FL, April 13, 2013.
47. Lee DH, Knight KR, Chang KW. “Validity of audiogram threshold interpolation in pediatric
oncology patients.” American Society of Pediatric Otolaryngology 28th Annual Meeting,
Arlington, VA, April 25-28, 2013.
48. Czechowicz JA, Chang KW. “Longitudinal analysis of growth curves in children following
adenotonsillectomy.” American Society of Pediatric Otolaryngology 28th Annual Meeting,
Arlington, VA, April 26, 2013.
49. Sefi E, Brock P, Chang K, Neuwelt E, Knight K, Rajput K. “Validation of the SIOP Boston
ototoxicity scale: An international scale for the evaluation of platinum-induced ototoxicity in
cihldren.” 45th Congress of the International Society of Paediatric Oncology, Hong Kong, China,
September 27, 2013.
50. Chang KW. “Coblation techniques: Total, Intracapsular, and Lingual Tonsillectomy.” SENTAC
Pre-Conference Symposium (Tonsillectomy & Adenoidectomy: Care & Controversies),
December 5, 2013.
51. Czechowicz JA, Chang KW. “Impact of supraglottoplasty on growth and development of
infants with laryngomalacia.” American Society of Pediatric Otolaryngology 29th Annual
Meeting, Las Vegas, NV, May 16, 2014.
52. Bass JK, Hua C, Huang J, Onar-Thomas A, Ness KK, Jones S, White S, Bhagat SP, Chang KW,
Merchant TE. “Incidence, onset, severity, and long-term progression of hearing loss in patients
treated with cranial radiation therapy for childhood cancer.” European Symposium on Late
Complications After Childhood Cancer, Edinburgh, Scotland, September 15-16, 2014.
53. Chang KW. “Hearing outcomes of atresia surgery and auditory implants in patients with
congenital aural atresia.” 1st Congress of the International Society of Auricular Reconstruction,
Paris, France, September 27, 2014.
54. Chang KW. “Comparison of thinning vs non-thinning techniques for placement of Ponto
osseointegrated auditory implants in children.” 14th Symposium on Cochlear Implants in
Children, Nashville, TN, December 11, 2014.
55. Chang KW. “Comparison of thinning vs non-thinning techniques for placement of Ponto
osseointegrated auditory implants in children.” 10th Asia Pacific Symposium on Cochlear
Implants and Related Sciences, China National Convention Center, Beijing, China, May 1, 2015.
56. Chang KW. “Hearing outcomes of atresia surgery versus bone anchored implants in patients
with congenital aural atresia: A systematic review.” 10th Asia Pacific Symposium on Cochlear
Implants and Related Sciences, China National Convention Center, Beijing, China, May 1, 2015.
57. Chang KW, Oghalai JS. “Cognitive outcomes and familial stress after cochlear implantation in
deaf children with and without developmental delays.” 10 th Asia Pacific Symposium on
Curriculum Vitae
Kay W. Chang, MD
12
Cochlear Implants and Related Sciences, China National Convention Center, Beijing, China, May
2, 2015.
58. Chang KW. “Comparison of thinning vs non-thinning techniques for bone anchored implants.”
5th International Congress on Bone Conduction Hearing and Related Technologies, Lake Louise,
Canada, May 21, 2015.
59. Chang KW. “Assessment and prevention of ototoxicity in children receiving chemotherapy.”
AAO-HNSF 2015 Annual Meeting Miniseminar: “Ototoxic or not: Innovations in the
management of ototoxicity”, Dallas, Texas, September 28, 2015.
60. Chang KW. “Update on radiological and genetic evaluation of congenital SNHL.” 1st Cairo
Cochlear Implant Congress, Intercontinental Cairo Semiramis Hotel, Cairo, Egypt, February 6,
2016.
61. Chang KW. “Pediatric cochlear implantation: Indications, techniques, and future directions.” 1st
Cairo Cochlear Implant Congress, Intercontinental Cairo Semiramis Hotel, Cairo, Egypt,
February 7, 2016.
62. Chang KW, Amoils M, Popelka GR, Kearns J, Larky J, Farquhar M, Sussman K, Blevins NH,
Fitzgerald MB. “The BabyTalk Program: Factors influencing auditory development after
teletherapy in children with hearing loss ages 0-3 years.” 1st Cairo Cochlear Implant Congress,
Intercontinental Cairo Semiramis Hotel, Cairo, Egypt, February 7, 2016.
63. Bliss MR, Truong MT, Chang KW. “Three dimensional printing in microtia repair: Facilitating
teaching and achieving symmetry.” Triological Society Spring COSM, Chicago, IL, May 20,
2016.
64. Baird BJ, Chang KW. “Oral mucocutaneous manifestation of EBV-associated
lymphoproliferative disorder in a healthy pediatric patient.” American Society of Pediatric
Otolaryngology Spring COSM, Chicago, IL, May 20, 2016.
INVITED PRESENTATIONS
1. Chang KW. “Failed newborn hearing screening – what to do next?” 76th Annual Postgraduate
Convention, Loma Linda, March 2, 2008.
2. Chang KW. “Advances in tonsillectomy: Technology vs. technique.” 76 th Annual Postgraduate
Convention, Loma Linda, March 2, 2008.
3. Chang KW. “Advances in tonsillectomy: technology vs. technique.” Symposium on Coblation
Innovation. COSM 2008, Orlando, May 2, 2008.
4. Chang KW. “What’s new in tonsillectomy technology.” 2010 Ultimate Colorado Mid-Winter
Meeting, Vail, Colorado, January 26, 2010.
5. Chang KW. “Assessment of ototoxicity in chemotherapy patients.” Oregon Health Sciences
University, Multnomah Athletic Club, Portland, OR, October 11, 2010.
6. Chang KW. “Current concepts in the evaluation of pediatric SNHL.” Oregon Health Sciences
University, Department of Otolaryngology SJH 5314, Portland, OR, October 12, 2010.
7. Chang KW. “Current concepts in the evaluation of congenital sensorineural hearing loss.”
Tongren Hospital, Beijing, China, January 4, 2012.
8. Chang KW. “Beyond T&A: Options for persisting pediatric OSA after adenotonsillectomy.”
Beijing Children’s Hospital, Beijing, China, January 5, 2012.
9. Chang KW. “Current concepts in the evaluation of congenital sensorineural hearing loss.” Eye
& ENT Hospital of Fudan University, Shanghai, China, January 11, 2012.
Curriculum Vitae
Kay W. Chang, MD
13
10. Chang KW. “Current concepts in the practical evaluation of congenital SNHL with radiology
and genetics.” 2012 Ultimate Colorado Mid-Winter Meeting, Vail, Colorado, February 5, 2012.
11. Grundfast K, Casselbrant M, Carvalho D, Chang K, Lusk R. “Common pediatric otologic
dilemmas.” 2012 Ultimate Colorado Mid-Winter Meeting, Vail, Colorado, February 5, 2012.
12. Chang KW, Messner AH. “Optimizing postoperative recovery of the tonsillectomy patient.”
2012 Ultimate Colorado Mid-Winter Meeting, Vail, Colorado, February 5, 2012.
13. Pransky S, Prager J, Manning S, Chang K. “Pediatric airway round table.” 2012 Ultimate
Colorado Mid-Winter Meeting, Vail, Colorado, February 5, 2012.
14. Chang KW. “Clinically accurate assessment and grading of ototoxicity in pediatric oncology
patients.” CPC Seminar, St. Jude Children’s Research Hospital, Memphis, Tennessee, October 1,
2012.
15. Chang KW. “Evaluation of cisplatin ototoxicity.” Memphis Speech & Hearing Center (MSHC),
University of Memphis, Memphis, Tennessee, October 2, 2012.
16. Chang KW. “Emerging trends in the diagnosis of congenital SNHL.” 2013 Ultimate Colorado
Mid-Winter Meeting, Vail, Colorado, February 6, 2013.
17. Chang KW. “Guest professorship: Microtia and canal atresia reconstruction.” Eye & ENT
Hospital of Fudan University, Shanghai, China, January 8-10, 2014.
18. Chang KW. “Issues in pediatric bone anchored implant surgery.” Oticon Medical Scientific
Meeting, Copenhagen, Denmark, January 27, 2014.
19. Chang KW. “Coblation techniques for treatment of sleep disturbed breathing.” 2014 Ultimate
Colorado Mid-Winter Meeting, Vail, Colorado, February 5, 2014.
20. Chang KW. “Workup of child with congenital sensorineural hearing loss.” 2014 Ultimate
Colorado Mid-Winter Meeting, Vail, Colorado, February 6, 2014.
21. Chang KW. Keynote: “Hearing outcomes of atresia surgery in patients with congenital aural
atresia.” 2014 Shanghai International Symposium on Microtia-Atresia and Hearing
Reconstruction, Shanghai, China, March 16, 2014.
22. Chang KW. Keynote: “Emerging trends in the diagnosis of congenital SNHL.” 96 th Annual
Taiwan Otolaryngology Society Meeting, Hsinchu, Taiwan, May 3, 2014.
23. Chang KW. Keynote: “Options for audiological rehabilitation in patients undergoing ear
reconstruction.” 1st Congress of the International Society of Auricular Reconstruction, Paris,
France, September 27, 2014.
24. Backous D, Chang KW. (moderators) “Advancements in implant surgery.” 14th Symposium on
Cochlear Implants in Children, Nashville, TN, December 11, 2014.
25. Chang KW. “Hearing outcomes of atresia surgery versus bone-anchored hearing aid in patients
with congenital aural atresia.” 2015 Ultimate Colorado Mid-Winter Meeting, Vail, Colorado,
February 3, 2015.
26. Chang KW, Knight K (co-chairs). “Assessment of Ototoxicity.” 21st Annual Blood-Brain Barrier
Consortium Meeting, Stevenson, WA, March 19-21, 2015.
27. Chang KW. “Panelist of Roundtable Discussion on Bone-Anchored Hearing Aids &
Bonebridge.” 10th Asia Pacific Symposium on Cochlear Implants and Related Sciences, China
National Convention Center, Beijing, China, May 1, 2015.
28. Chang KW (moderator). AAO-HNSF 2015 Annual Meeting Miniseminar: “Ototoxic or not:
Innovations in the management of ototoxicity”, Dallas, Texas, September 28, 2015.
Curriculum Vitae
Kay W. Chang, MD
14
29. Chang KW. “Options for audiological management of congenital aural atresia.” The 2 nd China
International Forum of Pediatric Development, Pediatric Otolaryngology Session, Beijing, China,
October 10, 2015.
30. Naseer UA, Chang KW, Sheikh AE, Ruiz MA, Olgun L, Chiossone JA, Lavy J, El khaboury M,
George M, Chaudry I, De Raeve L. “Global cochlear implantation economics: Current status and
future prospects.” (round-table discussion) 1st Cairo Cochlear Implant Congress,
Intercontinental Cairo Semiramis Hotel, Cairo, Egypt, February 5, 2016.
31. Müller J, Chang KW, Handousa A, Khater A, Wahba H, Taibah K, De Raeve L, Ruiz MA,
Donnelly N. “Binaural hearing in CI.” (panel) 1st Cairo Cochlear Implant Congress,
Intercontinental Cairo Semiramis Hotel, Cairo, Egypt, February 6, 2016.
32. Naseer UA, Chang KW, Baki FA, Kassouma J, Müller J, Chiossone JA, Kandari M, Khalil S, El
Dessouky T. “CI device selection.” (panel) 1st Cairo Cochlear Implant Congress, Intercontinental
Cairo Semiramis Hotel, Cairo, Egypt, February 7, 2016.
33. Chang K, Choo, D, Don D, Freyer D, Geller J, Hayashi R, Lee A, Lieu J, Rangaswami A,
Waldman E. “OTO-104 Otoprotection Expert Panel.” St. Louis, MO, March 11, 2016.
CME COURSES AND OTHER PRESENTATIONS
1. Chang KW. “Pediatric obstructive sleep apnea.” Presented at Grand Rounds, Pittsburgh, PA,
January 13, 1999.
2. Chang KW. “The Cochlear Amplifier: Concepts and experiments in auditory physiology.”
Presented at Grand Rounds, Pittsburgh, PA, January 12, 2000.
3. Chang KW. “Update in Pediatric Otolaryngology.” Presented at ENT Grand Rounds, Stanford
University, CA, September 7, 2000.
4. Chang KW. “Pediatric obstructive sleep apnea.” Resident Education Conference, Stanford
University, CA, September 21, 2000.
5. Chang KW. “Pediatric hearing loss.” Resident Education Conference, Stanford University, CA,
January 18, 2001.
6. Chang KW. “Evaluation and management of ear problems in children.” Pediatric Grand
Rounds, Stanford University, CA, April 27, 2001.
7. Chang KW. “External and middle ear effects on otoacoustic emissions.” Seminar: Clinical
Applications of Otoacoustic Emissions, Lucile Packard Children’s Hospital, Department of
Pediatric Audiology, June 16, 2001.
8. Chang KW. “Ear problems in the pediatric population.” Ninth Annual Pediatric Update (CME
meeting), July 20-21, 2001.
9. Chang KW. “Monitoring and management of ototoxic therapies.” Presented at ENT Grand
Rounds, Stanford University, CA, December 6, 2001.
10. Chang KW. “Panel Discussion: Atelectasis.” Western Section of the American Society of
Pediatric Otolaryngology (WESPO) Annual Meeting, Lucile Packard Children’s Hospital, March
16, 2002.
11. Chang KW. “Monitoring and management of ototoxic therapies.” Annual Symposium, Stanford
University, June 21, 2002.
12. Chang KW, Tran L. “Cochlear embryology and physiology.” Resident Education Conference,
Stanford University, November 7, 2002.
Curriculum Vitae
Kay W. Chang, MD
15
13. Chang KW, Pollard J. “Pediatric obstructive sleep apnea.” Resident Education Conference,
Stanford University, March 6, 2003.
14. Chang KW. “Pediatric Airway Update 2003.” Annual Symposium, Stanford University, June
21, 2003.
15. Chang KW. “An in vivo model for the prevention of cisplatin-induced ototoxicity using lactate
and N-acetylcysteine.” Pediatric Oncology Conference, LPCH Board Room, March 11, 2004.
16. Chang KW. “Congenital Problems.” Temporal Bone Microdissection Lab – Pediatric Otology,
Stanford University, February 28, 2004.
17. Chang KW, Ruffy M. “Embryology of the Head & Neck.” Resident Education Conference,
Stanford University, April 29, 2004.
18. Chang KW. “Congenital Malformations of the Ear.” Resident Education Conference, Stanford
University, April 29, 2004.
19. Chang KW. “Evaluation and management of congenital ear problems.” LPCH CME Course,
Pismo Beach Pediatric Clinical Update, San Luis Obispo, CA, May 22, 2004.
20. Chang KW, Chen J. “Evaluation of the child with sensory hearing loss.” Resident Education
Conference, Stanford University, May 27, 2004.
21. Chang KW. “Is CO2 laser still standard therapy for RRP?” Annual Symposium, Stanford
University, June 19, 2004.
22. Chang KW. “What a pediatrician needs to know about cochlear implants.” 12 th Annual
Pediatric Update, Frances C. Arrillaga Alumni Center, Stanford University, July 17, 2004.
23. Chang KW. “Microtia and ear canal atresia.” Pediatric Otolaryngology Update 2004, LPCH
CME Course, The Ritz-Carlton, San Francisco, November 6, 2004.
24. Chang KW. “What to expect from pediatric cochlear implants.” Pediatric Otolaryngology
Update 2004, LPCH CME Course, The Ritz-Carlton, San Francisco, November 7, 2004.
25. Nguyen B, Barnes P, Chang KW. “Utility of temporal bone CT measurements in the evaluation
of inner ear malformations resulting in sensorineural hearing loss.” Medical Student Research
Symposium, Stanford University, May 11, 2005.
26. Chang KW. “Microtia and ear canal atresia.” Temporal Bone Microdissection Lab – Pediatric
Otology, Stanford University, May 21, 2005.
27. Blevins N, Chang KW, Larky J. “Cochlear implants: Better hearing through advanced
technology: What, when, and for whom?” Fairchild Auditorium, Stanford University, June 16,
2005.
28. Chang KW. “Treatment of vocal cord paralysis in children.” Annual Symposium, Stanford
University, June 18, 2005.
29. Chang KW, Swamy R. “Evaluation of the child with sensorineural hearing loss.” Resident
Education Conference, Stanford University, March 30, 2006.
30. Chang KW, Sunder S. “Congenital malformations of the ear.” Resident Education Conference,
Stanford University, March 30, 2006.
31. Chinosornvatana N, Chang KW. “Grading of ototoxicity.” Medical Student Research
Symposium, Stanford University, May 17, 2006.
32. Chang KW. “Innovations in pediatric tonsillectomy.” Invited speaker. Palo Alto Medical
Foundation, July 18, 2006.
Curriculum Vitae
Kay W. Chang, MD
16
33. Chang KW. “Complications of otitis media.” Pediatric Otolaryngology Update 2006, LPCH
CME Course, Crowne Plaza Cabana, Palo Alto, October 27, 2006.
34. Chang KW. “Atypical mycobacterial infections.” Pediatric Otolaryngology Update 2006, LPCH
CME Course, Crowne Plaza Cabana, Palo Alto, October 27, 2006.
35. Chang KW. “Managing tympanic membrane perforations.” Pediatric Otolaryngology Update
2006, LPCH CME Course, Crowne Plaza Cabana, Palo Alto, October 27, 2006.
36. Chang KW. “Panel: Otitis Media.” Pediatric Otolaryngology Update 2006, LPCH CME Course,
Crowne Plaza Cabana, Palo Alto, October 27, 2006.
37. Chang KW. “Management of Microtia and Atresia.” Stanford Otology & Neurotology Update
2006, Stanford CME Course, Stanford Court Hotel, San Francisco, November 3, 2006.
38. Chang KW. “Ototoxicity and Chemoprotection.” Stanford Otology & Neurotology Update 2006,
Stanford CME Course, Stanford Court Hotel, San Francisco, November 3, 2006.
39. Chang KW. “Congenital atresia.” Temporal Bone Microdissection Lab – Pediatric Otology,
Stanford University, March 26, 2007.
40. Chang KW, Sunder S. “Evaluation of ototoxicity and chemoprotective strategies.” Resident
Education Conference, Stanford University, May 24, 2007.
41. Chang KW. “Congenital laryngeal stenosis.” Annual Symposium, Stanford University, June 23,
2007.
42. Chang KW. “Clinically relevant assessment and classification of drug-induced ototoxicity in
pediatric patients.” Pediatric Pulmonary Conference, LPCH, September 27, 2007.
43. Chang KW. “Debate: Is surgery for chronic sinusitis in children indicated?” Pediatric
Otolaryngology Update 2008, LPCH CME Course, Crowne Plaza Cabana, Palo Alto, March 28,
2008.
44. Chang KW. “Update on laryngeal stenosis.” Pediatric Otolaryngology Update 2008, LPCH CME
Course, Crowne Plaza Cabana, Palo Alto, March 29, 2008.
45. Chang KW. “Pediatric Otology: Congenital Ear Anomalies.” Temporal Bone Microdissection
Lab – Pediatric Otology, Stanford University, April 28, 2008.
46. Chang KW. “Management of Microtia and Atresia.” Stanford Otology & Neurotology Update
2008, Stanford CME Course, Stanford Court Hotel, San Francisco, November 6, 2008.
47. Chang KW. “Pearls and pitfalls in interpreting auditory physiologic studies in pediatric
patients.” Resident Education Conference, Stanford University, January 29, 2009.
48. Chang KW. “Pediatric Otology: Congenital Ear Anomalies.” Temporal Bone Microdissection
Lab – Pediatric Otology, Stanford University, May 18, 2009.
49. Chang KW. “A practical grading system for evaluating cisplatin ototoxicity in children.” LPCH
Pediatric Oncology Protocol Meeting, Stanford University, September 23, 2009.
50. Chang KW. “Atresia and congenital conductive hearing loss.” Chandler Tripp School, San Jose,
October 27, 2009.
51. Popelka GR, Chang KW. “Practical methods for monitoring ototoxicity in chemotherapy
patients.” Cancer Education Seminar Series, Stanford University School of Medicine Division of
Oncology, December 1, 2009.
52. Chang KW. “Work-up of pediatric SNHL.” Resident Education Conference, Stanford
University, April 8, 2010.
Curriculum Vitae
Kay W. Chang, MD
17
53. Chang KW. “Assessment of Ototoxicity in Chemotherapy Patients.” Pediatric Research Study
Group, Alway Medical Center Building M212, Stanford University School of Medicine, April 26,
2010.
54. Chang KW. “Neonatal unilateral hearing screen referrals, canal atresia, and microtia,” NICU
Clinical Consensus Conference, Lucile Packard Children’s Hospital at Stanford, May 24, 2010.
55. Oghalai J, Blevins N, Chang KW, Cheng A, Lalwani A, Lustig L, Telian S. “Hearing Loss in
Children.” Stanford Otology Course 2010, Stanford CME Course, Li Ka Shing Center for
Learning & Knowledge, Stanford University, November 5, 2010.
56. Chang KW. “How to not miss a cholesteatoma.” Pediatric Otolaryngology Update 2011, LPCH
CME Course, Li Ka Shing Center for Learning and Knowledge, Stanford, CA, February 11, 2011.
57. Chang KW, Cheng A, Oghalai J, Rosbe K, Rosen F, Winzelberg J. “How best to care for the child
with a unilateral hearing loss.” Pediatric Otolaryngology Update 2011, LPCH CME Course, Li
Ka Shing Center for Learning and Knowledge, Stanford, CA, February 11, 2011.
58. Chang KW, Winzelberg J. “Audiometric interpretation.” Pediatric Otolaryngology Update 2011,
LPCH CME Course, Li Ka Shing Center for Learning and Knowledge, Stanford, CA, February
12, 2011.
59. Chang KW. “Pediatric Audiology.” Resident Education Conference, Stanford University,
February 2, 2012.
60. Chang KW. “Genetic hearing loss.” Resident Education Conference, Stanford University,
February 9, 2012.
61. Chang KW. “Does treating gastroesophageal reflux help babies with laryngomalacia?”
Intensive Course in Clinical Research (ICCR), Stanford Center for Clinical and Translational
Education and Research, March 30, 2012.
62. Anavitarte A, Winzelberg J, Chang K, Cheng A. “The effect of unilateral hearing loss on speech
and language development.” 29th Annual Medical Student Research Symposium, Stanford
University School of Medicine, May 3, 2012.
63. Chang KW. “The medical work-up of pediatric SNHL.” Haman Elementary School, Santa
Clara, California, May 15, 2012.
64. Lee J, Chang KW. “Grading of ototoxicity in children.” 2012 Residency Research Symposium,
Stanford, California, June 15, 2012.
65. Chan DK, Chang KW. “GJB2-associated hearing loss: genotypic and phenotypic variability.”
2012 Residency Research Symposium, Stanford, California, June 15, 2012. (won 1st prize)
66. Nadaraja G, Chang KW. “Hearing outcomes of surgery versus BAHA in patients with
congenital aural atresia: A systematic review.” 2012 Residency Research Symposium, Stanford,
California, June 15, 2012. (won runner-up prize)
67. Oghalai J, Chang KW, Cheng A, Welling DB. “Pediatric Otology.” Stanford Otology Course
2012, Stanford CME Course, Li Ka Shing Center for Learning & Knowledge, Stanford University,
November 1-3, 2012.
68. Chang KW. “Minimizing the effects of ototoxicity-induced hearing loss in children receiving
chemotherapy.” OHNS Research Day, Clark Auditorium, Stanford University, November 16,
2012.
69. Chang KW. “Congenital anomalies of the external and middle ears.” Resident Education
Conference, Stanford University, March 21, 2013.
Curriculum Vitae
Kay W. Chang, MD
18
70. Chang KW. “Can standardization of ototoxicity reporting using the SIOP Ototoxicity Scale help
improve clinical trials to reduce ototoxicity in pediatric oncology patients?” Peds Hem/Onc
Faculty Research Conference, Lokey Stem Cell G1161 Large Conference Room, Stanford
University, June 14, 2013.
71. Czechowizc J, Chang KW. “Analysis of growth curves in children following
adenotonsillectomy.” 2013 Residency Research Symposium, Stanford, California, June 14, 2013.
(won runner-up prize)
72. Lee J, Chang KW. “Validity of audiogram threshold interpolation in pediatric oncology
patients.” 2013 Residency Research Symposium, Stanford, California, June 14, 2013.
73. Chang KW. “Evolution of treatments for permanent pediatric CHL.” Resident Education
Conference, Stanford University, March 27, 2014.
74. Czechowizc J, Chang KW. “Impact of supraglottoplasty on growth and development of infants
with laryngomalacia.” 2014 Residency Research Symposium, Stanford, California, June 13, 2014.
75. Chang KW. “Managing Atresia/Microtia.” Stanford Otology Course 2014, Stanford CME
Course, Li Ka Shing Center for Learning & Knowledge, Stanford University, November 8, 2014.
76. Chang KW. “Issues in pediatric bone-anchored implant surgery: Challenges met by modern
tissue preservation surgical technique.” 1st Oticon Medical China Scientific Seminar on Middle
Ear Implants, Hong Kong, November 12, 2014.
77. Chang KW. “Issues in pediatric bone-anchored implant surgery: Challenges met by modern
tissue preservation surgical technique.” 1st Oticon Medical China Scientific Seminar on Middle
Ear Implants, Beijing, November 14, 2014.
78. Chang KW. “Monitoring the effects of ototoxicity-induced hearing loss in children receiving
chemotherapy.” Pediatric Audiology Conference, Stanford Ear Institute, February 17, 2015.
79. Chang KW. “Management of pediatric atresia and microtia patients.” Resident Education
Conference, Stanford University, March 26, 2015.
80. Chang KW. “Tissue preservation technique for bone anchored implants in children.” Oticon
Medical Scientific Symposium, China National Convention Center, Beijing, China, May 1, 2015.
81. Chang KW. “T&A Today: New Techniques and Tools.” Primary Care Challenges in Pediatric
Otolaryngology: A Case-Based Approach, Stanford CME Course, Monterey, CA, May 8, 2015.
82. Chang KW. “Clinical Practice Guidelines for Otitis Media.” Primary Care Challenges in
Pediatric Otolaryngology: A Case-Based Approach, Stanford CME Course, Monterey, CA, May
9, 2015.
83. Chang KW. “Microtia: Latest Ideas for World Class Results.” Primary Care Challenges in
Pediatric Otolaryngology: A Case-Based Approach, Stanford CME Course, Monterey, CA, May
9, 2015.
84. Chang KW. “Ear Cases and Q&A.” Primary Care Challenges in Pediatric Otolaryngology: A
Case-Based Approach, Stanford CME Course, Monterey, CA, May 9, 2015.
85. Chang KW. “Microtia and canal atresia reconstruction.” Chandler Tripp School, San Jose, May
18, 2015.
86. Chang KW. “Coblation techniques for treatment of tonsillar hypertrophy.” AAO-HNSF 2015
Annual Meeting, Exhibit Hall Product Theater, Dallas, Texas, September 28, 2015.
87. Chang KW. “Assessment and prevention of ototoxicity in children receiving chemotherapy.”
OHNS Research Day, Li Ka Shing Center Berg Hall, Stanford University, October 30, 2015.
Curriculum Vitae
Kay W. Chang, MD
88. Chang KW. “Microtia and Atresia: Latest Ideas for World Class Results.” Chandler Tripp
School, San Jose, May 16, 2016.
19
Related documents